Pure Global

Roche human epithelial factor receptor second protein gene two-color in situ hybrid nucleic acid probe combination - Taiwan Registration 8ad0960f609ff229ae2709a801b16dcb

Access comprehensive regulatory information for Roche human epithelial factor receptor second protein gene two-color in situ hybrid nucleic acid probe combination in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 8ad0960f609ff229ae2709a801b16dcb and manufactured by ROCHE DIAGNOSTICS GMBH;; VENTANA MEDICAL SYSTEMS, INC.. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
8ad0960f609ff229ae2709a801b16dcb
Registration Details
Taiwan FDA Registration: 8ad0960f609ff229ae2709a801b16dcb
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Roche human epithelial factor receptor second protein gene two-color in situ hybrid nucleic acid probe combination
TW: ็พ…ๆฐไบบ้กžไธŠ็šฎๅ› ๅญๆŽฅๅ—้ซ”็ฌฌไบŒ่›‹็™ฝ่ณชๅŸบๅ› ้›™่‰ฒๅŽŸไฝ้›œไบคๆ ธ้…ธๆŽข้‡็ต„ๅˆ
Risk Class 3
Cancelled

Registration Details

8ad0960f609ff229ae2709a801b16dcb

DHA00602311902

Company Information

Product Details

The purpose of the Roche Human Epithelial Factor Receptor Second Protein Gene Two-color in Situ Hybrid Nucleic Acid Probe Combination is to quantify the amplification of human epithelial factor second protein (HER2) gene directly under light microscopy by formalin fixation and paraffin-embedded human breast cancer and gastric cancer tissue samples, including the gastroesophageal junction, with Roche Vantana automatic multifunctional histopathological staining system, using two-color in situ hybrid staining technology.

B Hematology, pathology, and genetics

B.1860 Immunopathological histochemistry reagents and kits

Contract manufacturing;; input

Dates and Status

Dec 26, 2011

Dec 26, 2021

Sep 08, 2023

Cancellation Information

Logged out

ๆœชๅฑ•ๅปถ่€Œ้€พๆœŸ่€